Manganese superoxide dismutase gene polymorphisms in psoriatic arthritis

Disease Markers

Volumn 19, Issue 6, 2003, Pages 263-265

  Yen, Jeng Hsien ^a,b,e   Tsai, Wen Chun ^a   Lin, Chia Hui ^a   Ou, Tsan Teng ^c   Hu, Chaur Jong ^d   Liu, Hong Wen ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Kaohsiung Municipal United Hospital   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d JEN AI HOSPITAL   (Taiwan)

^e NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS;

EID: 3042719225     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/734242     Document Type: Article

References (22)

1. R.M. Bennett, Psoriatic arthritis, in: Arthritis and allied conditions, W.J. Koopman, ed., Philadelphia, Lippincott Williams & Wilkins, 2001, pp. 1345-1361.
2. D.D. Gladman, C. Cheung, C.M. Ng and J.A. Wade, HLA-C locus alleles in patients with psoriatic arthritis (PsA), Human Immunol 60 (1999), 259-261.
3. P. Rahman, C.T. Schentag and D.D. Gladman, Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis, Arthritis Rheum 42 (1999), 822-823.
4. G. Drewa, E. Krzyzynska-Malinowska, A. Wozniak, F. Protas-Drozd, C. Mila-Kierzenkowska, M. Rozwodowska, B. Kowaliszyn and R. Czajkowski, Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis, Med Sci Monit 8 (2002), BR338-343.
5. Y. Miyachi and Y. Niwa, Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leukocytes, Arch Dermatol Res 275 (1983), 23-26.
6. A. Er-raki, M. Charveron and J.L. Bonafe, Increased superoxide anion production in dermal fibroblasts of psoriatic patients, Skin Pharmacol 6 (1993), 253-258.
7. W. Lontz, A. Sirsjo, W. Liu, M. Lindberg, O. Rollman and H. Torma, Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha, Free Radic Biol Med 18 (1995), 349-355.
8. B. Woolf, On estimating the relation between blood group and disease, Ann Hum Genet 20 (1955), 251-253.
9. J.B.S. Haldane, The estimation and significance of the logarithm of a ration of frequencies, Ann Hum Genet 20 (1955), 309-311.
10. C.C. Winterbourn, Superoxide as an intracellular radical sink, Free Radic Biol Med 14 (1993), 85-90.
11. G.E.O. Borgstahi, H.E. Parge, M.J. Mickey, W.F. Beyer, Jr., R.A. Hallewell and J.A. Tainer, The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles, Cell 71 (1992), 107-118.
12. B.N. Ames, M.K. Shigenaga and T.M. Hagen, Oxidants, antioxidants, and the degenerative diseases of aging, Proc Natl Acad Sci USA 90 (1993), 7915-7922.
13. V. Calabrese, G. Scapagnini, A.M. Giuffrida Stella, T.E. Bates and J.B. Clark, Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity, Neurochem Res 26 (2001), 739-764.
14. K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R.L. Russell, C.S. Atwood, A.B. Johnson, Y. Kress, H.V. Vinters, M. Tabaton, S. Shimohama, A.D. Cash, S.L. Siedlak, P.L. Harris, P.L. Jones, R.B. Petersen, G. Perry and M.A. Smith, Mitochondrial abnormalities in Alzheimer's disease, J Neurosci 21 (2001), 3017-3023.
15. G.E.O. Borgstahl, H.E. Parge, M.J. Hickey, M.J. Johnson, M. Boissinot, R.A. Hallewell, J.R. Lepock, D.E. Cabelli and J.A. Tainer, Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface, Biochemistry 35 (1996), 4287-4297.
16. S. Shimoda-Matsubayashi, H. Matsumine, T. Kobayashi, Y. Nakagawa-Hattori, Y. Shimizu and Y. Mizuno, Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene, Biochem Biophys Res Commun 226 (1996), 561-565.
17. B.D. Lemire, C. Fankhauser, A. Baker and G. Schatz, The mitochondrial targeting function of randomly generated peptide sequences correlates with predicted helical amphiphilicity, J Biol Chem 264 (1989), 20206-20215.
18. S. Shimoda-Matsubayashi, T. Hattori, H. Matsumine, A. Shinohara, A. Yoritaka, H. Mori, T. Kondo, M. Chiba and Y. Mizuno, MnSOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control, Neurology 49 (1997), 1257-1262.
19. F. Pociot, T. Lorenzen and J. Nerup, A manganese superoxide dismutase (SOD2) gene polymorphism in insulin-dependent diabetes mellitus, Dis Markers 11 (1993), 267-274.
20. F. Pociot, K.S. Ronningen, R. Bergholdt, T. Lorenzen, J. Johannesen, K. Ye, C.A. Dinarello and J. Nerup, Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes-evidence for polygenicity in man, Autoimmunity 19 (1994), 169-178.
21. C.B. Ambrosone, J.L. Freudenheim, PA. Thompson, E. Bowman, J.E. Vena, J.R. Marshall, S. Graham, R. Laughlin, T. Nemoto and P.G. Shields, Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer, Cancer Res 59 (1999), 602-606.
22. R. Izutani, S. Asano, M. Imano, D. Kuroda, M. Kato and H. Ohyanagi, Expression of manganese superoxide dismutase in esophageal and gastric cancers, J Gastroenterol 33 (1998), 816-822.